Breaking News Instant updates and real-time market news.

EBS

Emergent BioSolutions

$43.84

1.38 (3.25%)

06:39
09/03/19
09/03
06:39
09/03/19
06:39

Emergent BioSolutions awarded $2B contract by U.S. HHS

Emergent BioSolutions announced a contract award by the Office of the Assistant Secretary for Preparedness and Response, or ASPR, in the U.S. Department of Health and Human Services, or HHS, valued at approximately $2B over 10 years for the continued supply of ACAM2000, or Smallpox Vaccine, into the U.S. Strategic National Stockpile, or SNS. The actual number of ACAM2000 doses to be procured is dependent on certain timing and tiered-pricing terms that are subject to the discretion of ASPR. ACAM2000 vaccine is the only vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. This contract for the procurement of ACAM2000 vaccine consists of a one-year base period of performance, valued at approximately $170M, and nine option years. The company expects to deliver into the SNS a majority of the doses under the base year by year end 2019, the effect of which is already included in the company's full year financial forecast, which was recently reaffirmed on August 1. This multiple year contract is intended to support the replacement of the smallpox vaccine stockpile and follows the conclusion of a prior 10-year, $425M contract to establish domestic warm-base manufacturing capabilities and procure smallpox vaccines issued by the U.S. government April 1, 2008.

  • 04

    Sep

  • 09

    Sep

EBS Emergent BioSolutions
$43.84

1.38 (3.25%)

06/03/19
WELS
06/03/19
NO CHANGE
Target $61
WELS
Market Perform
Size, timeline of Emergent new contract 'a clear positive,' says Wells Fargo
Wells Fargo analyst David Maris notes that Emergent BioSolutions announced that it was awarded a 10-year contract award by the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services valued at approximately $535M. The company stated that the U.S. government has never awarded a 10-year contract for Vaccinia Immune Globulin Intravenous, and the last VIGIV contract was a 1-year $26M contract that was signed in February 2018, he points out, adding the contract prior to that was a 3-year $92M contract. The analyst views the size and timeline of the newly announced VIGIV contract as a clear positive. Further, Maris continues to think the ACAM2000 follow on contracts is a "when" not an "if" and expects the shares to trade higher when this contract negotiation is completed. He reiterates a Market Perform rating and a $61 price target on the stock.
05/09/19
WELS
05/09/19
NO CHANGE
Target $61
WELS
Market Perform
Emergent BioSolutions price target lowered to $61 from $68 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target on Emergent BioSolutions to $61 and kept his Market Perform rating after its miss on Q1 revenue and earnings last week. The analyst also lowers his FY19 and FY20 EPS outlook by 7c and 41c to $3.01 and $3.27 respectively, reflecting the delays in its negotiations for a follow-on contact for its AMAC2000 Smallpox Vaccine and the management's expectations for its FY19 earnings to be "even more heavily back half weighted."
04/22/19
CANT
04/22/19
NO CHANGE
Target $75
CANT
Overweight
Emergent shares largely pricing in Teva approval, says Cantor Fitzgerald
The FDA on Friday granted Teva Pharmaceutical (TEVA) final approval for its generic version of Narcan, Cantor Fitzgerald analyst Brandon Folkes tells investors in a research note. The analyst views the announcement as largely anticipated following the expiration of Teva's 30- month stay last month. Shares of Emergent BioSolutions (EBS) are down 18.7% since reporting Q4 earnings, largely driven by the anticipation of a final approval of Teva's generic naloxone, says Folkes. While Friday's approval is a negative and will continue to create an overhang on Emergent shares, the recent weakness has "adequately accounted for this overhang," he contends. As such, Folkes keeps an Overweight rating on Emergent BioSolutions with a $75 price target.
04/02/19
WELS
04/02/19
NO CHANGE
Target $68
WELS
Market Perform
BARDA passing on Pfenex good news for Emergent, says Wells Fargo
The decision by the Department of Health and Human Services' Biomedical Advanced Research and Development Authority not to exercise development options on Pfenex's (PFNX) anthrax program is good news for Emergent BioSolutions (EBS), Wells Fargo analyst David Maris tells investors in a research note. Emergent currently sells BioThrax, a vaccine indicated for the active immunization for the prevention of disease caused by anthrax, Maris points out. In addition, NuThrax is the company's most important pipeline product as it represents an improvement on BioThrax, says the analyst. He sees the move by BARDA on the Pfenex program as underscoring its belief in the BioThrax and NuThrax programs. Maris keeps a Market Perform rating on Emergent BioSolutions with a $68 price target. The stock in early trading is up 58c to $50.81.

TODAY'S FREE FLY STORIES

UCBI

United Community Banks

$29.30

0.12 (0.41%)

17:02
10/22/19
10/22
17:02
10/22/19
17:02
Earnings
United Community Banks reports Q3 adjusted EPS 63c, consensus 58c »

On an operating basis,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

NEM

Newmont Goldcorp

$37.80

-0.17 (-0.45%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
Newmont Goldcorp starting production at Penasquito Mine in Mexico »

Newmont Goldcorp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ATR

AptarGroup

$116.78

-1.22 (-1.03%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
AptarGroup says Activ-Blister packaging solution approved by FDA »

AptarGroup announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 12

    Nov

BUSE

First Busey

$25.45

0.05 (0.20%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Earnings
First Busey reports Q3 adjusted EPS 55c, consensus 52c »

For the third quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SNAP

Snap

$14.00

-0.58 (-3.98%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
Snap says each daily active user opens Snapchat 30 times per day on average »

Says community grew to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 21

    Nov

SMH

Market Vectors Semiconductor

$123.51

-0.88 (-0.71%)

, TXN

Texas Instruments

$128.61

-2.32 (-1.77%)

16:57
10/22/19
10/22
16:57
10/22/19
16:57
Hot Stocks
Semiconductor stocks fall after Texas Instruments gives dismal outlook »

Shares of Market Vectors…

SMH

Market Vectors Semiconductor

$123.51

-0.88 (-0.71%)

TXN

Texas Instruments

$128.61

-2.32 (-1.77%)

INTC

Intel

$52.00

-0.12 (-0.23%)

QCOM

Qualcomm

$78.46

-0.5 (-0.63%)

TSM

TSMC

$50.66

0.65 (1.30%)

AVGO

Broadcom

$287.54

-2.03 (-0.70%)

NVDA

Nvidia

$195.52

-0.64 (-0.33%)

ASML

ASML

$255.32

-5.14 (-1.97%)

ADI

Analog Devices

$110.91

-0.18 (-0.16%)

LRCX

Lam Research

$234.91

-3.77 (-1.58%)

AMD

AMD

$31.51

-0.54 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

REED

Reed's

$0.70

-0.0297 (-4.07%)

16:51
10/22/19
10/22
16:51
10/22/19
16:51
Syndicate
Reed's announces common stock offering »

Reed's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
10/22/19
10/22
16:45
10/22/19
16:45
Hot Stocks
Breaking Hot Stocks news story  »

PB Bancorp trading…

KRG

Kite Realty Group

$17.32

0.135 (0.79%)

16:42
10/22/19
10/22
16:42
10/22/19
16:42
Hot Stocks
Kite Realty Group completes disposition program 'fortifying' balance sheet »

Kite Realty Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

USO

United States Oil Fund

$11.35

0.145 (1.29%)

16:40
10/22/19
10/22
16:40
10/22/19
16:40
General News
API crude inventories for week of October 18 »

API reports that crude…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRN

K12

$24.84

-0.56 (-2.20%)

16:37
10/22/19
10/22
16:37
10/22/19
16:37
Hot Stocks
K12 reports Q1 adjusted EBITDA $3.3M vs. $8.8M last year »

Reports Q1 Enrollment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BIIB

Biogen

$281.89

58.32 (26.09%)

, PG

Procter & Gamble

$122.19

3.15 (2.65%)

16:36
10/22/19
10/22
16:36
10/22/19
16:36
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

The major averages ended…

BIIB

Biogen

$281.89

58.32 (26.09%)

PG

Procter & Gamble

$122.19

3.15 (2.65%)

UTX

United Technologies

$141.42

3.18 (2.30%)

MCD

McDonald's

$199.26

-10.585 (-5.04%)

TRV

Travelers

$130.22

-11.55 (-8.15%)

UPS

UPS

$116.10

-2.46 (-2.07%)

BA

Boeing

$337.45

6.33 (1.91%)

STMP

Stamps.com

$90.77

14.65 (19.25%)

LYFT

Lyft

$43.60

2.74 (6.71%)

SERV

ServiceMaster

$44.78

-11.295 (-20.14%)

HAS

Hasbro

$100.00

-20.11 (-16.74%)

NFLX

Netflix

$266.69

-11.3 (-4.06%)

VZ

Verizon

$60.80

0.06 (0.10%)

DIS

Disney

$132.44

2.16 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 29

    Oct

  • 30

    Oct

  • 05

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 09

    Dec

MTH

Meritage Homes

$74.88

0.23 (0.31%)

16:36
10/22/19
10/22
16:36
10/22/19
16:36
Earnings
Meritage Homes raises FY19 EPS view to $5.50-$5.70 from $5.20-$5.50 

Consensus $5.46.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 19

    Nov

LRN

K12

$24.84

-0.56 (-2.20%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Earnings
K12 sees Q2 revenue $255M-$260M , consensus $255.93M »

Sees Q2 CapEx $9.0M-$11M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MTH

Meritage Homes

$74.88

0.23 (0.31%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Earnings
Meritage Homes reports Q3 EPS $1.79, consensus $1.50 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 19

    Nov

LRN

K12

$24.84

-0.56 (-2.20%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Earnings
K12 sees FY20 revenue $1.02B-$1.035B , consensus $1.03B »

Sees FY20 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MGNX

MacroGenics

$11.01

-0.37 (-3.25%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Hot Stocks
MacroGenics says first primary endpoint of PFS achieved in Phase 3 SOPHIA study »

MacroGenics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AMZN

Amazon.com

$1,766.07

-18.66 (-1.05%)

, MSFT

Microsoft

$136.39

-2.05 (-1.48%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Hot Stocks
DoD's Esper removes himself from JEDI contract review, citing son's work »

Statement From Chief…

AMZN

Amazon.com

$1,766.07

-18.66 (-1.05%)

MSFT

Microsoft

$136.39

-2.05 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

  • 21

    Nov

TRMK

Trustmark

$34.83

-0.15 (-0.43%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Earnings
Trustmark reports Q3 EPS 64c, consensus 62c »

Reports Q3 net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

FULT

Fulton Financial

$16.76

0.09 (0.54%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Earnings
Fulton Financial reports Q3 EPS 37c, consensus 35c »

"Overall, we were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LRN

K12

$24.84

-0.56 (-2.20%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Earnings
K12 reports Q1 EPS (25c), consensus (19c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

IBIO

iBio

$0.57

0.0722 (14.44%)

16:31
10/22/19
10/22
16:31
10/22/19
16:31
Earnings
iBio reports on NYSE American noncompliance notice, compliance plan »

iBio announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTB

Butterfield

$30.90

-0.09 (-0.29%)

16:31
10/22/19
10/22
16:31
10/22/19
16:31
Earnings
Butterfield reports Q3 core EPS 91c, consensus 91c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LECO

Lincoln Electric

$88.21

1.14 (1.31%)

16:30
10/22/19
10/22
16:30
10/22/19
16:30
Hot Stocks
Lincoln Electric raises quarterly dividend 4.3% to 49c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 12

    Nov

16:30
10/22/19
10/22
16:30
10/22/19
16:30
Options
Preliminary option volume of 17.7M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.